Ocular Therapeutix Earnings
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.36
Ocular Therapeutix earnings summary
Ocular Therapeutix is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $-0.36. In its most recent report on Aug 3, 2026 (Q2 2026), OCUL posted EPS of $-0.35. Revenue for the quarter was $13.5 million.
Across the last 16 reports, OCUL shares moved an average of 4.5% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
OCUL earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 3, 2026 | — | $-0.35 | — | +9.2% |
| May 5, 2026 | — | $-0.40 | — | -5.1% |
| Feb 5, 2026 | — | $-0.27 | — | -3.1% |
| Nov 4, 2025 | — | $-0.38 | — | +4.1% |
| Aug 5, 2025 | — | $-0.39 | — | +3.4% |
| May 5, 2025 | — | $-0.38 | — | +2.3% |
| Mar 3, 2025 | — | $-0.25 | — | +2.4% |
| Nov 14, 2024 | — | $-0.22 | — | -3.6% |
| Aug 7, 2024 | — | $-0.26 | — | -2.8% |
| May 7, 2024 | — | $-0.49 | — | +9.0% |
| Mar 11, 2024 | — | $-0.12 | — | +0.3% |
| Nov 7, 2023 | — | $-0.25 | — | +8.3% |
| Aug 7, 2023 | — | $-0.26 | — | -3.4% |
| May 8, 2023 | — | $-0.39 | — | +4.0% |
| Mar 6, 2023 | — | $-0.19 | — | +1.8% |
| Nov 7, 2022 | — | $-0.31 | — | -8.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.